Company / EPS (Diluted)
uniQure N.V. EPS (Diluted) History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$4.92
FY2024
5-year range
-$6.47 / $7.04
FY2020-FY2024
Trend
+24.0%
vs FY2023
Sector context
#173 of 204
Health Care
What the data says
uniQure N.V.'s eps (diluted) of $-4.92 is lower than 85% of companies in the Health Care sector (FY2024). EPS (Diluted) returned to growth in FY2024 after 2 years of decline, reaching $-4.92.
Based on SEC 10-K filings.
-4.92 in FY2024.
Declined from $-2.71 to $-4.92 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 204This company -$4.92 Sector average -$0.89
▼
-449.8% below sector average
Key checks
Key Insights
- In FY2024, eps (diluted) increased 24.0% year-over-year.
- Ranks #173 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2021.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.58 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$4.92 | +24.0% |
| FY2023 | -$6.47 | -138.7% |
| FY2022 | -$2.71 | -138.5% |
| FY2021 | $7.04 | +350.5% |
| FY2020 | -$2.81 | +9.6% |
| FY2019 | -$3.11 | - |
| FY2018 | - | - |
| FY2017 | -$3.72 | -27.8% |
| FY2016 | -$2.91 | - |
| FY2015 | - | - |
As of FY2024 · SEC Form 10-K · Last checked Jul 3, 2026